Lisa A Jackson
Overview
Explore the profile of Lisa A Jackson including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
224
Citations
11370
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Naleway A, Crane B, Irving S, Daley M, Dixon B, Donahue J, et al.
Pediatr Infect Dis J
. 2025 Feb;
44(2S):S105-S107.
PMID: 39951085
We described vaccinations during pregnancies starting in 2002 through 2022 in 8 Vaccine Safety Datalink healthcare organizations in the United States. During this period, the number of vaccinations per pregnancy...
2.
Zhang B, Fong Y, Dang L, Fintzi J, Chen S, Wang J, et al.
Nat Commun
. 2025 Jan;
16(1):759.
PMID: 39824819
Neutralizing antibody titer has been a surrogate endpoint for guiding COVID-19 vaccine approval and use, although the pandemic's evolution and the introduction of variant-adapted vaccine boosters raise questions as to...
3.
El Sahly H, Anderson E, Jackson L, Neuzil K, Atmar R, Bernstein D, et al.
Vaccine
. 2025 Jan;
47:126689.
PMID: 39756216
Introduction: Pandemic influenza vaccine development focuses on the hemagglutinin (HA) antigen for potency and immunogenicity. Antibody responses targeting the neuraminidase (NA) antigen, or the HA stalk domain have been implicated...
4.
Duffy J, Yih W, Walton K, DeSilva M, Glanz J, Hambidge S, et al.
Infection
. 2024 Nov;
PMID: 39565485
Background: The JYNNEOS vaccine (two doses given 28 days apart) was recommended in the United States for people at high risk of exposure to monkeypox virus during the 2022 mpox...
5.
Babu T, Jackson L, El Sahly H
J Infect Dis
. 2024 Oct;
231(1):44-48.
PMID: 39412209
The development of SARS-CoV-2 next-generation vaccines with the potential for increased effectiveness, durability, breadth, and ability to decrease transmission are of public health importance. We highlight alternative routes of administration...
6.
Fong Y, Dang L, Zhang B, Fintzi J, Chen S, Wang J, et al.
Clin Infect Dis
. 2024 Sep;
80(1):223-227.
PMID: 39325506
For COVAIL recipients of a coronavirus disease 2019 (COVID-19) Sanofi booster vaccine, neutralizing antibody titers were assessed as a correlate of risk (CoR) of COVID-19. Peak and exposure-proximal titers were...
7.
Boyce T, McClure D, Hanson K, Daley M, DeSilva M, Irving S, et al.
Pharmacoepidemiol Drug Saf
. 2024 Aug;
33(8):e5863.
PMID: 39155049
Purpose: Vaccine-associated enhanced disease (VAED) is a theoretical concern with new vaccines, although trials of authorized vaccines against SARS-CoV-2 have not identified markers for VAED. The purpose of this study...
8.
Kharbanda E, DeSilva M, Lipkind H, Romitti P, Zhu J, Vesco K, et al.
JAMA Pediatr
. 2024 Jul;
178(8):823-829.
PMID: 38949821
Importance: COVID-19 vaccination is recommended throughout pregnancy to prevent pregnancy complications and adverse birth outcomes associated with COVID-19 disease. To date, data on birth defects after first-trimester vaccination are limited....
9.
Hechter R, Qian L, Liu I, Sy L, Ryan D, Xu S, et al.
JAMA Netw Open
. 2024 Jun;
7(6):e2415220.
PMID: 38842808
Importance: People with HIV (PWH) may be at increased risk for severe outcomes with COVID-19 illness compared with people without HIV. Little is known about COVID-19 vaccination coverage and factors...
10.
Markowitz L, Hopkins Jr R, Broder K, Lee G, Edwards K, Daley M, et al.
Vaccine
. 2024 Feb;
42 Suppl 3:125549.
PMID: 38341293
During the COVID-19 pandemic, candidate COVID-19 vaccines were being developed for potential use in the United States on an unprecedented, accelerated schedule. It was anticipated that once available, under U.S....